Cargando…
Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival
Patients with cancer are at high risk of developing venous thromboembolism (VTE), including deep venous thrombosis and pulmonary embolism. Compared to non-cancer patients, VTE in cancer is more frequently associated with clinical consequences, including recurrent VTE, bleeding, and an increase in th...
Autores principales: | Falanga, Anna, Vignoli, Alfonso, Diani, Erika, Marchetti, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417933/ https://www.ncbi.nlm.nih.gov/pubmed/22915978 http://dx.doi.org/10.2147/PROM.S10099 |
Ejemplares similares
-
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
por: Giossi, Riccardo, et al.
Publicado: (2021) -
Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022) -
Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014) -
Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021) -
Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)